Active substance
Fluconazole
- SFDA 37
- US FDA 48
- Health Canada 29
- US price lines 6
- NHS prices 6
- WHO EML 1
- Safety 5
SFDA Saudi Arabia — SFDA human drug list
| Trade name | Strength | Form · route | Pack | Public price | Type | Company | Status |
|---|---|---|---|---|---|---|---|
| CANDEUR 150MG CAPSULES | 150 mg | Capsule · Oral use | 1 Blister | SAR 17.80 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| CANDEUR 2 mg/ml Solution For Infusion | 2 mg/ml | Solution · Intravenous use | 1 Vial | SAR 26.05 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| CANDEUR 2 mg/ml Solution For Infusion | 2 mg/ml | Solution · Intravenous use | 1 Vial | SAR 52.15 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Valid |
| CANDIVAST 150MG CAP | 150 mg | Capsule · Oral use | 1 Blister | SAR 19.45 | Generic · Prescription | THE ARAB PHARMACEUTICAL MANUFACTURING PSC (SAHAB) | Valid |
| CANDIVAST 50MG CAP | 50 mg | Capsule · Oral use | 7 Blister | SAR 45.45 | Generic · Prescription | THE ARAB PHARMACEUTICAL MANUFACTURING PSC (SAHAB) | Valid |
| DIFLUCAN 150 mg capsule | 150 mg | Capsule · Oral use | 1 Blister | SAR 19.45 | NCE · Prescription | PFIZER HOLDING FRANCE | Valid |
| DIFLUCAN 200 mg capsule | 200 mg | Capsule · Oral use | 7 Blister | SAR 340.60 | NCE · Prescription | PFIZER HOLDING FRANCE | Valid |
| DIFLUCAN 50 mg capsule | 50 mg | Capsule · Oral use | 7 Blister | SAR 45.45 | NCE · Prescription | PFIZER HOLDING FRANCE | Valid |
| DURACAN 150MG CAPSULE | 150 mg | Capsule, soft · Oral use | 1 Blister | SAR 19.45 | Generic · Prescription | Jamjoom Pharmaceuticals Factory Company | Valid |
| FLOCAZOLE 150 MG CAPSULES | 150 mg | Capsule · Oral use | 1 Blister | SAR 19.45 | Generic · Prescription | SPIMACO ADDWAEIH | Valid |
| FLOCAZOLE 50 MG CAPSULES | 50 mg | Capsule · Oral use | 7 Blister | SAR 45.45 | Generic · Prescription | SPIMACO ADDWAEIH | Valid |
| FLUCAND 200MG-100ML INFUSION VIAL | 2 mg/ml | Solution for infusion · Intravenous use | 1 Vial | SAR 56.55 | Generic · Prescription | Hikma Pharmaceuticals PLC | Valid |
| FLUCAZOL 150 mg Capsule | 150 mg | Capsule, hard · Oral use | 1 Blister | SAR 15.05 | Generic · Prescription | National Pharmaceutical Industries Co. (SAOG) | Valid |
| FLUCAZOL 50 mg Capsule | 50 mg | Capsule, hard · Oral use | 7 Blister | SAR 42.70 | Generic · Prescription | National Pharmaceutical Industries Co. (SAOG) | Valid |
| FLUCO-SOL 2MG/ML SOLUTION FOR I.V. INFUSION | 2 mg/ml | Solution for injection · Intravenous use | 1 Vial | SAR 57.95 | Generic · Prescription | Pharmaceutical Solution Industries (PSI) | Valid |
| FLUKAS 100 VIAL | 2 mg/ml | Solution for injection · Intravenous use | 1 Vial | SAR 21.05 | Generic · Prescription | LES LABORATOIRES MEDIS | Valid |
| FLUKAS 200 VIAL | 2 mg/ml | Solution for injection · Intravenous use | 1 Vial | SAR 29.40 | Generic · Prescription | LES LABORATOIRES MEDIS | Valid |
| FUNGIMID 150MG CAPSULE | 150 mg | Capsule · Oral use | 1 Blister | SAR 16.70 | Generic · Prescription | Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co. | Valid |
| FUNGIMID 50MG CAPSULE | 50 mg | Capsule · Oral use | 7 Blister | SAR 19.45 | Generic · Prescription | Middle East Pharmaceutical and Chemical Industries and Medical Appliances Co. | Valid |
| FUNZOL 150MG CAPSULES | 150 mg | Capsule · Oral use | 1 Blister | SAR 15.05 | Generic · Prescription | The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM) | Valid |
| Funzol | 150 mg | Capsule · Oral use | 168 Blister | SAR 2528.40 | Generic · Prescription | The Jordanian Pharmaceutical Manufacturing Medical Equipment Co. Ltd. (JPM) | Valid |
| ORAMAX 150MG CAPSULES | 150 mg | Capsule · Oral use | 1 Blister | SAR 15.05 | Generic · Prescription | Gulf Pharmaceutical Industries (Julphar) | Valid |
| ODECON 150 mg Capsule | 150 mg | Capsule · Oral use | 1 Bottle | SAR 15.05 | Generic · Prescription | NEOPHARMA | Suspended |
| CANDEUR 200MG CAPSULES | 200 mg | Capsule · Oral use | 7 Blister | SAR 253.35 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Invalid · Not Marketed |
| CANDEUR 50MG CAPSULES | 50 mg | Capsule · Oral use | 7 Blister | SAR 42.70 | Generic · Prescription | Tabuk Pharmaceutical Manufacturing Company | Invalid · Not Marketed |
12 more — full table
Indications — CHI Daman Drug Formulary
ADULT ACUTE LYMPHOCYTIC LEUKEMIA (ALL)-ADVERSE REACTIONS MANAGEMENT; ADULT ACUTE MYELOID LEUKAEMIA (AML); ANTIMICROBIAL PROPHYLAXIS IN CANCER PATIENTS; CANDIDIASIS OF SKIN AND NAIL; CUTANEOUS LEISHMANIASIS; ECZEMA; ESOPHAGEAL CANDIDIASIS & OROPHARYNGEAL CANDIDIASIS; FUNGAL GIT - COCCIDIOIDOMYCOSIS; FUNGAL GIT - CRYPTOCOCCOSIS; FUNGAL INFECTIONS OF THE GENITAL TRACT - CANDIDIASIS OF VULVA AND VAGINA & CANDIDIASIS OF OTHER UROGENITAL SITES; HUMAN IMMUNODEFICIENCY VIRUS; Invasive Candidiasis and Candidemia; ONYCHOMYCOSIS ,TINEA UNGUIUM; PEDIATRIC ACUTE LYMPHOBLASTIC LEUKAEMIA (ALL)-ADVERSE REACTIONS MANAGEMENT; Pyogenic Arthritis; RENAL TRANSPLANT; TRAVEL RELATED INFECTIONS-TREATMENT
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| DIFLUCAN | 50MG; 100MG; 200MG; 150MG | tablet · oral | PFIZER | Prescription | 29 Jan 1990 |
| DIFLUCAN | 50MG/5ML; 200MG/5ML | for suspension · oral | PFIZER | Prescription | 23 Dec 1993 |
| FLUCONAZOLE IN SODIUM CHLORIDE 0.9% | 200MG/100ML (2MG/ML); 100MG/50ML (2MG/ML); 400MG/200ML (2MG/ML) | injectable · injection | HIKMA PHARMS | Prescription | 29 Jul 2004 |
| FLUCONAZOLE IN SODIUM CHLORIDE 0.9% | 200MG/100ML (2MG/ML); 400MG/200ML (2MG/ML) | injectable · injection | FRESENIUS KABI USA | Prescription | 29 Jul 2004 |
| FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 200MG/100ML (2MG/ML); 400MG/200ML (2MG/ML) | injectable · injection | HOSPIRA | Prescription | 29 Jul 2004 |
| FLUCONAZOLE | 50MG; 100MG; 150MG; 200MG | tablet · oral | DR REDDYS LABS INC | Prescription | 29 Jul 2004 |
| FLUCONAZOLE | 50MG; 100MG; 150MG; 200MG | tablet · oral | CHARTWELL | Prescription | 29 Jul 2004 |
| FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 200MG/100ML (2MG/ML); 400MG/200ML (2MG/ML) | injectable · injection | BAXTER HLTHCARE | Prescription | 29 Jul 2004 |
| FLUCONAZOLE IN SODIUM CHLORIDE 0.9% | 200MG/100ML (2MG/ML) | injectable · injection | HIKMA FARMACEUTICA | Prescription | 23 Aug 2005 |
| FLUCONAZOLE | 50MG; 100MG; 200MG; 150MG | tablet · oral | UNIQUE | Prescription | 28 Sep 2005 |
| FLUCONAZOLE | 50MG; 100MG; 150MG; 200MG | tablet · oral | GLENMARK PHARMS LTD | Prescription | 25 Jan 2006 |
| FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 200MG/100ML (2MG/ML); 400MG/200ML (2MG/ML) | injectable · injection | HIKMA PHARMS | Prescription | 30 Jul 2008 |
| FLUCONAZOLE | 50MG; 100MG; 150MG; 200MG | tablet · oral | AUROBINDO PHARMA | Prescription | 7 Oct 2008 |
| FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 200MG/100ML (2MG/ML); 400MG/200ML (2MG/ML) | injectable · injection | INFORLIFE | Prescription | 30 Jul 2009 |
| FLUCONAZOLE | 50MG/5ML; 200MG/5ML | for suspension · oral | AUROBINDO PHARMA | Prescription | 18 Sep 2009 |
| FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 200MG/100ML (2MG/ML); 400MG/200ML (2MG/ML); 100MG/50ML (2MG/ML) | injectable · injection | WOODWARD | Prescription | 26 May 2010 |
| FLUCONAZOLE | 50MG; 100MG; 150MG; 200MG | tablet · oral | ANI PHARMS | Prescription | 7 Mar 2011 |
| FLUCONAZOLE IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 200MG/100ML (2MG/ML); 400MG/200ML (2MG/ML) | injectable · injection | HIKMA FARMACEUTICA | Prescription | 30 Jan 2012 |
| FLUCONAZOLE | 50MG; 100MG; 150MG; 200MG | tablet · oral | ZYDUS PHARMS | Prescription | 16 Feb 2017 |
| FLUCONAZOLE | 200MG/5ML | for suspension · oral | ZHEJIANG POLY PHARM | Prescription | 21 Sep 2023 |
| FLUCONAZOLE | 50MG; 100MG; 150MG; 200MG | tablet · oral | FDC LTD | Prescription | 8 Jan 2026 |
| DIFLUCAN IN SODIUM CHLORIDE 0.9% | 200MG/100ML (2MG/ML); 400MG/200ML (2MG/ML) | injectable · injection | PFIZER | Discontinued | 29 Jan 1990 |
| DIFLUCAN IN SODIUM CHLORIDE 0.9% IN PLASTIC CONTAINER | 200MG/100ML (2MG/ML); 400MG/200ML (2MG/ML) | injectable · injection | PFIZER | Discontinued | 29 Jan 1990 |
| DIFLUCAN IN DEXTROSE 5% IN PLASTIC CONTAINER | 200MG/100ML (2MG/ML); 400MG/200ML (2MG/ML) | injectable · injection | PFIZER | Discontinued | 29 Jan 1990 |
| FLUCONAZOLE | 50MG; 100MG; 150MG; 200MG | tablet · oral | TEVA | Discontinued | 29 Jul 2004 |
23 more — full table
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| ACT FLUCONAZOLE | 02281260 | 50 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| ACT FLUCONAZOLE | 02281279 | 100 MG | TABLET · ORAL | TEVA CANADA LIMITED |
| AG-FLUCONAZOLE | 02555891 | 150 MG | CAPSULE · ORAL | ANGITA PHARMA INC. |
| APO-FLUCONAZOLE | 02237370 | 50 MG | TABLET · ORAL | APOTEX INC |
| APO-FLUCONAZOLE | 02237371 | 100 MG | TABLET · ORAL | APOTEX INC |
| APO-FLUCONAZOLE-150 | 02241895 | 150 MG | CAPSULE · ORAL | APOTEX INC |
| BIO-FLUCONAZOLE | 02462168 | 150 MG | CAPSULE · ORAL | BIOMED PHARMA |
| CANESORAL | 02311690 | 150 MG | CAPSULE · ORAL | BAYER INC |
| DIFLUCAN | 00891835 | 2 MG / ML | SOLUTION · INTRAVENOUS | PFIZER CANADA ULC |
| DIFLUCAN | 02024152 | 50 MG / 5 ML | POWDER FOR SOLUTION · ORAL | PFIZER CANADA ULC |
| DIFLUCAN ONE | 02141442 | 150 MG | CAPSULE · ORAL | PFIZER CANADA ULC |
| FLUCONAZOLE | 02517396 | 50 MG | TABLET · ORAL | SANIS HEALTH INC |
| FLUCONAZOLE | 02517418 | 100 MG | TABLET · ORAL | SANIS HEALTH INC |
| FLUCONAZOLE | 02534886 | 50 MG | TABLET · ORAL | SIVEM PHARMACEUTICALS ULC |
| FLUCONAZOLE | 02534894 | 100 MG | TABLET · ORAL | SIVEM PHARMACEUTICALS ULC |
| FLUCONAZOLE 150 | 02352133 | 150 MG | CAPSULE · ORAL | APOTEX INC |
| FLUCONAZOLE IN SODIUM CHLORIDE INJECTION USP | 02261472 | 2 MG / ML | SOLUTION · INTRAVENOUS | BAXTER CORPORATION |
| FLUCONAZOLE INJECTION SDZ | 02388448 | 2 MG / ML | SOLUTION · INTRAVENOUS | SANDOZ CANADA INCORPORATED |
| FLUCONAZOLE-150 | 02521229 | 150 MG | CAPSULE · ORAL | SANIS HEALTH INC |
| JAMP FLUCONAZOLE 150 MG | 02547864 | 150 MG | CAPSULE · ORAL | JAMP PHARMA CORPORATION |
| M-FLUCONAZOLE-150 | 02553406 | 150 MG | CAPSULE · ORAL | MANTRA PHARMA INC |
| MAR-FLUCONAZOLE-150 | 02428792 | 150 MG | CAPSULE · ORAL | MARCAN PHARMACEUTICALS INC |
| MYLAN-FLUCONAZOLE | 02245292 | 50 MG | TABLET · ORAL | MYLAN PHARMACEUTICALS ULC |
| MYLAN-FLUCONAZOLE | 02245293 | 100 MG | TABLET · ORAL | MYLAN PHARMACEUTICALS ULC |
| NRA-FLUCONAZOLE-150 | 02433702 | 150 MG | CAPSULE · ORAL | NORA PHARMA INC |
4 more — full table
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | FLUCONAZOLE 10 MG/ML SUSP | $0.27773 | per ML | 23 Sep 2026 |
| US NADAC | FLUCONAZOLE 100 MG TABLET | $0.22275 | per EA | 23 Sep 2026 |
| US NADAC | FLUCONAZOLE 150 MG TABLET | $0.46976 | per EA | 23 Sep 2026 |
| US NADAC | FLUCONAZOLE 200 MG TABLET | $0.37982 | per EA | 23 Sep 2026 |
| US NADAC | FLUCONAZOLE 40 MG/ML SUSP | $0.54679 | per ML | 23 Sep 2026 |
| US NADAC | FLUCONAZOLE 50 MG TABLET | $0.20764 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Fluconazole 150mg capsule and Clotrimazole 2% cream | £11.07 | 1 pack | 1 Oct 2026 |
| NHS Drug Tariff | Fluconazole 150mg capsules | £0.78 | 1 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Fluconazole 200mg capsules | £3.58 | 7 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Fluconazole 200mg/5ml oral suspension | £66.42 | 35 ml | 1 Oct 2026 |
| NHS Drug Tariff | Fluconazole 50mg capsules | £0.78 | 7 capsule | 1 Oct 2026 |
| NHS Drug Tariff | Fluconazole 50mg/5ml oral suspension | £30.74 | 35 ml | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
WHO WHO Model List of Essential Medicines (2025)
- 6.3. Antifungal medicines · core
Cryptococcosis; Candidosis
Parenteral > General injections > IV: 2 mg per mL in vial | Oral > Liquid: 50 mg per 5 mL; 50 mg per 5 mL powder for oral liquid (EMLc) | Oral > Solid > capsule: 50 mg
Safety signals and safety-related labeling changes
- US FDA 12 Feb 2024 DIFLUCAN — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Patient Counseling Information / Patient Information / Medication Guide - US FDA 12 Feb 2024 DIFLUCAN — safety-related labeling change
Labeling sections changed: Contraindications; Warnings and Precautions; Adverse Reactions; Drug Interactions; Patient Counseling Information / Patient Information / Medication Guide - EMA PRAC 9 Feb 2017 PRAC signal: Spontaneous abortion during pregnancy and stillbirth
Action for MAH: update of the product information: Yes - EMA PRAC 12 Jan 2017 PRAC signal: Spontaneous abortion during pregnancy and stillbirth
Action for MAH: update of the product information: No - EMA PRAC 13 May 2016 PRAC signal: Spontaneous abortion during pregnancy and stillbirth
Action for MAH: update of the product information: No
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.